Morning vs. afternoon: timing of immunotherapy may impact lung cancer outcomes
Knowledge-focused
Recruiting now
This study looks at whether getting immunotherapy in the morning or afternoon changes how well it works for people with stage II-III lung cancer before surgery. About 156 participants will receive standard treatment plus immunotherapy at different times of day. The goal is to see…
Phase: PHASE3 • Sponsor: Hunan Province Tumor Hospital • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC